{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:56:28Z","timestamp":1773017788983,"version":"3.50.1"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"American Cancer Society and Pfizer Global Medical","award":["63354905"],"award-info":[{"award-number":["63354905"]}]},{"name":"Health Disparity Research"},{"name":"Department of Defense Congressionally Directed Medical Research","award":["PC220551"],"award-info":[{"award-number":["PC220551"]}]},{"DOI":"10.13039\/100005292","name":"Brigham and Women\u2019s Hospital Department of Surgery","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prostate Cancer Foundation and American Cancer Society","award":["23YOUN25"],"award-info":[{"award-number":["23YOUN25"]}]},{"DOI":"10.13039\/100000090","name":"Department of Defense Congressionally Directed Medical Research Program","doi-asserted-by":"crossref","award":["PC220342"],"award-info":[{"award-number":["PC220342"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Concerns persist that low-risk prostate cancer in non-Hispanic Black men may be more aggressive, with clinicians uncertain whether active surveillance should be used in this population. Using the Surveillance, Epidemiology, and End Results Prostate Cancer Specialized Database (2010-2020), we analyzed 106\u2009486 men with low-risk prostate cancer, of whom 16.6% were non-Hispanic Black. Active surveillance or watchful waiting was less frequently used in non-Hispanic Black men than in non-Hispanic White men (32.9% vs 37.5%). In fact, non-Hispanic Black men showed consistently lower use of active surveillance\/watchful waiting over the years (adjusted odds ratio\u2009=\u20090.91, 95% confidence interval [CI]\u2009=\u20090.86 to 0.95), with absolute differences ranging from 3.4% to 8.5%. In multivariable competing risks analysis, 10-year prostate cancer\u2013specific mortality did not statistically significantly differ by race (subdistribution hazard ratio\u2009=\u20091.03, 95% CI\u2009=\u20090.66 to 1.60). These findings suggest that active surveillance\/watchful waiting is a safe option for non-Hispanic Black men, and it may be underutilized in this group, despite comparable long-term cancer-specific outcomes.<\/jats:p>","DOI":"10.1093\/jnci\/djaf224","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T11:41:09Z","timestamp":1754739669000},"page":"541-544","source":"Crossref","is-referenced-by-count":0,"title":["Active surveillance for low-risk prostate cancer: long-term utilization and outcomes among Black men"],"prefix":"10.1093","volume":"118","author":[{"given":"Zhiyu","family":"Qian","sequence":"first","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3962-6049","authenticated-orcid":false,"given":"Stephan","family":"Korn","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1255-9337","authenticated-orcid":false,"given":"Hanna","family":"Zurl","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4507-3414","authenticated-orcid":false,"given":"Daniel","family":"Stelzl","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Dagnino","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6165-3125","authenticated-orcid":false,"given":"Mansoo","family":"Cho","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danesha","family":"Daniels","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2619-1389","authenticated-orcid":false,"given":"Stuart","family":"Lipsitz","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7596-9049","authenticated-orcid":false,"given":"Hari S","family":"Iyer","sequence":"additional","affiliation":[{"name":"Section of Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey , New Brunswick, NJ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-8529","authenticated-orcid":false,"given":"Alexander P","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Urology, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]},{"name":"Center for Surgery and Public Health, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3857-9276","authenticated-orcid":false,"given":"Quoc-Dien","family":"Trinh","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Pittsburgh Medical Center , Pittsburgh, PA,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,8,14]]},"reference":[{"key":"2026030819565868500_djaf224-B1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.eururo.2023.09.002","article-title":"Uncovering the changing treatment landscape for low-risk prostate cancer in the USA from 2010 to 2020: insights from the national cancer data base","volume":"84","author":"Beatrici","year":"2023","journal-title":"European Urol"},{"key":"2026030819565868500_djaf224-B2","doi-asserted-by":"crossref","first-page":"e231439","DOI":"10.1001\/jamanetworkopen.2023.1439","article-title":"Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US","volume":"6","author":"Cooperberg","year":"2023","journal-title":"JAMA Network Open"},{"key":"2026030819565868500_djaf224-B3","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1001\/jama.2024.6695","article-title":"Long-term outcomes in patients using protocol-directed active surveillance for prostate cancer","volume":"331","author":"Newcomb","year":"2024","journal-title":"JAMA"},{"key":"2026030819565868500_djaf224-B4","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMc1900333","article-title":"Active surveillance for low-risk prostate cancer in black patients","volume":"380","author":"Butler","year":"2019","journal-title":"New England Journal of Medicine"},{"key":"2026030819565868500_djaf224-B5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1001\/jama.2020.17020","article-title":"Association between African American race and clinical outcomes in men treated for low-risk prostate cancer with active surveillance","volume":"324","author":"Deka","year":"2020","journal-title":"Jama"},{"key":"2026030819565868500_djaf224-B6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.urology.2013.09.038","article-title":"Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience","volume":"83","author":"Odom","year":"2014","journal-title":"Urology."},{"key":"2026030819565868500_djaf224-B7","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1200\/JCO.2012.47.0302","article-title":"African American men with very low\u2013risk prostate cancer exhibit adverse oncologic outcomes after radical prostatectomy: should active surveillance still be an option for them?","volume":"31","author":"Sundi","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026030819565868500_djaf224-B8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/JU.0000000000000621","article-title":"African American race is not associated with risk of reclassification during active surveillance: results from the canary prostate cancer active surveillance study","volume":"203","author":"Schenk","year":"2020","journal-title":"J Urol"},{"key":"2026030819565868500_djaf224-B9","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/j.clgc.2014.04.003","article-title":"Racial disparities in prostate cancer\u2013specific mortality in men with low-risk prostate","volume":"12","author":"Mahal","year":"2014","journal-title":"Cancer Clin Genitourin Cancer"},{"key":"2026030819565868500_djaf224-B10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.euo.2021.07.006","article-title":"Prostate cancer racial disparities: A systematic review by the prostate cancer foundation panel","volume":"5","author":"Mahal","year":"2022","journal-title":"European Urol Oncol"},{"key":"2026030819565868500_djaf224-B11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","article-title":"Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort","volume":"77","author":"Tosoian","year":"2020","journal-title":"Eur Urol"},{"key":"2026030819565868500_djaf224-B12","author":"SEER"},{"key":"2026030819565868500_djaf224-B13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jama.2023.26491","article-title":"Functional outcomes after localized prostate cancer treatment","volume":"331","author":"Al Awamlh","year":"2024","journal-title":"JAMA"},{"key":"2026030819565868500_djaf224-B14","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1200\/JCO.2010.31.1217","article-title":"Cost implications of the rapid adoption of newer technologies for treating prostate cancer","volume":"29","author":"Nguyen","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026030819565868500_djaf224-B15","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.22.02203","article-title":"Racism does not cause prostate cancer, it causes prostate cancer death","volume":"41","author":"Vickers","year":"2023","journal-title":"J Clin Oncol"},{"key":"2026030819565868500_djaf224-B16","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1001\/jamaoncol.2019.0826","article-title":"Association of black race with prostate cancer\u2013specific and other-cause mortality","volume":"5","author":"Dess","year":"2019","journal-title":"JAMA Oncol"},{"key":"2026030819565868500_djaf224-B17","doi-asserted-by":"crossref","first-page":"e2144027","DOI":"10.1001\/jamanetworkopen.2021.44027","article-title":"Racial and ethnic disparities in prostate cancer outcomes in the veterans affairs health care system","volume":"5","author":"Yamoah","year":"2022","journal-title":"JAMA Network Open"},{"key":"2026030819565868500_djaf224-B18","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa2214122","article-title":"Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer","volume":"388","author":"Hamdy","year":"2023","journal-title":"N Engl J Med"},{"key":"2026030819565868500_djaf224-B19","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.2018.11716","article-title":"Prostate cancer\u2013specific mortality across Gleason scores in black vs nonblack men","volume":"320","author":"Mahal","year":"2018","journal-title":"JAMA"},{"key":"2026030819565868500_djaf224-B20","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1001\/jama.2019.2060","article-title":"Racial disparities in low-risk prostate cancer","volume":"321","author":"Ehdaie","year":"2019","journal-title":"JAMA"},{"key":"2026030819565868500_djaf224-B21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/pcan.2016.56","article-title":"Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review","volume":"20","author":"G\u00f6kce","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jnci\/advance-article-pdf\/doi\/10.1093\/jnci\/djaf224\/64046284\/djaf224.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/3\/541\/64046284\/djaf224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jnci\/article-pdf\/118\/3\/541\/64046284\/djaf224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T23:57:05Z","timestamp":1773014225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/118\/3\/541\/8234544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,8,14]]},"published-print":{"date-parts":[[2026,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djaf224","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,8,14]]}}}